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Abstract
 
Activation of polymorphonuclear leukocytes (PMNs) and adhesion to the endothelial lining is
 
a major cause of edema formation. Although known to be dependent on the function of 
 
b
 
2
 
 in-
tegrins (CD11/CD18), the precise mechanisms by which adherent PMNs may impair endo-
thelial barrier capacity remain unclear. Here, the role of transmembrane signaling by 
 
b
 
2
 
 inte-
grins in PMN-induced alterations in tight junctional permeability of cultured endothelial cell
(EC) monolayers was investigated. PMN activation, in the absence of proinflammatory stimuli,
 
was accomplished through antibody cross-linking of CD11b/CD18, mimicking adhesion-
dependent receptor engagement. CD18 cross-linking in PMNs added to the EC monolayer
provoked a prompt increase in EC permeability that coincided with a rise in EC cytosolic free
 
Ca
 
2
 
1
 
 and rearrangement of actin filaments, events similar to those evoked by chemoattractant
PMN activation. Cell-free supernatant obtained after CD18 cross-linking in suspended PMNs
triggered an EC response indistinguishable from that induced by direct PMN activation, and
caused clear-cut venular plasma leakage when added to the hamster cheek pouch in vivo prep-
aration. The PMN-evoked EC response was specific to 
 
b
 
2
 
 integrin engagement inasmuch as
 
antibody cross-linking of 
 
l
 
-selectin or CD44 was without effect on EC function. Our data
demonstrate a causal link between outside-in signaling by 
 
b
 
2
 
 integrins and the capacity of
PMNs to induce alterations in vascular permeability, and suggest a paracrine mechanism that
involves PMN-derived cationic protein(s) in the cellular crosstalk between PMNs and ECs.
Key words: inﬂammation • leukocyte extravasation • endothelium • vascular permeability • 
integrin signaling
 
Introduction
 
Activation and local accumulation of PMNs is an initial
event in the host defense against infectious and noxious
stimuli. Circulating PMNs respond to locally formed
chemotactic factors and emigrate to the surrounding tissue.
As a consequence of PMN activation and extravasation, the
endothelial cell (EC)
 
1
 
 barrier function is adjusted, leading
to increased vascular permeability for macromolecules and
plasma exudation (1, 2). These events represent cardinal
signs of inflammation, and they also contribute to the
pathogenesis of inflammatory disorders. Leukocytic 
 
b
 
2
 
 in-
tegrins (CD11/CD18) are critical in the PMN-induced EC
changes, because inhibition of PMN adhesion to ECs with
 
anti–
 
b
 
2
 
 integrin antibodies effectively prevents PMN-depen-
dent plasma leakage (2–4). However, engagement of 
 
b
 
2
 
 in-
tegrins not only governs cell attachment, but may also in-
fluence PMN activity in various ways.
Two major functions have been attributed to 
 
b
 
2
 
 inte-
grins: activation-induced ligand binding (inside-out signal-
ing) that mediates stable adhesion to cells or matrices, and,
consequent to ligand occupancy, signal transduction into
the cell (outside-in signaling; references 5, 6). Adherence-
dependent signaling via intracellular regulatory proteins is
likely to be involved in PMN cytoskeletal reorganization
and induction of cell motility, as well as triggering of secre-
tory events and respiratory burst (7–9). Thus, chemoattrac-
tant stimulation of PMNs may, via activation of 
 
b
 
2
 
 inte-
grins, initiate transmembrane signaling simultaneously with
substrate adhesion. Because both events have obvious con-
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Abbreviations used in this paper:
 
 BAEC, bovine aorta EC; [Ca
 
2
 
1
 
]
 
i
 
, intra-
cellular free Ca
 
2
 
1
 
; EBA, Evans blue dye-conjugated albumin; EC, endo-
thelial cell; HUVEC, human umbilical vein endothelial cell; TEER,
transendothelial electrical resistance. 
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sequences for EC barrier function, clarifying their down-
stream effects may provide better understanding of the
mechanisms behind PMN-induced changes in EC perme-
ability. To this end, antibody cross-linking of cell surface
receptors, considered to mimic natural ligand engagement,
may be experimentally employed to induce a signaling cas-
cade independently of the adhesive function of the recep-
tor. Thus, antibody-induced engagement of CD18 has
been shown to initiate a number of PMN activities, includ-
ing mobilization of cytosolic free calcium (10–12), protein
tyrosine phosphorylation (13, 14), and actin polymerization
and cytoskeletal rearrangement (12, 15).
We have reported previously on the kinetics of PMN-
induced changes in endothelial barrier function based on
measurements of electrical resistance, protein flux, and
PMN migration across EC monolayers cultured on perme-
able membranes (16). These and other data (17) indicate
that increase in EC permeability induced by activated
PMNs is linked to initial CD11/CD18–dependent adhe-
sive events and is independent of subsequent transendothe-
lial migration. However, the precise mechanisms by which
activated PMNs trigger an increase in EC permeability re-
main unresolved. We now demonstrate a direct and causal
association between adherence-dependent CD11/CD18
signaling and PMN-induced alterations in EC permeabil-
ity. Thus, engagement of 
 
b
 
2
 
 integrins in quiescent PMNs
through antibody receptor cross-linking is sufficient to pro-
voke an active and instantaneous response of EC and im-
paired EC barrier capacity indistinguishable from that
achieved by chemoattractant stimulation of the PMNs.
Our data further suggest that, downstream to 
 
b
 
2
 
 integrin
signaling, paracrine stimulation via PMN cationic pro-
tein(s) mediates the PMN-evoked EC responses.
 
Materials and Methods
 
Reagents.
 
Medium 199, RPMI 1640 (containing 
 
l
 
-glu-
tamine), FBS, trypsin-EDTA, PBS, and HBSS were from Life
Technologies. Gelatin, collagenase, penicillin, streptomycin, cata-
lase, FMLP, Evans blue dye, hexadecyltrimethylammonium bro-
mide, and tetramethylbenzidine were from Sigma-Aldrich. H
 
2
 
O
 
2
 
was from Merck KGaA, Biomatrix I was from Biomedical Tech-
nologies, Inc., and dextran 70 and Ficoll-Paque were from Amer-
sham Pharmacia Biotech. The basal culture medium consisted of
a 1:1 mixture of medium 199 and RPMI 1640 supplemented
with 20% heat-inactivated FBS, penicillin (100 U/ml), and strep-
tomycin (100 
 
m
 
g/ml). The following mouse mAbs against human
antigens were used: mAb IB4 against the common 
 
b
 
 chain
(CD18) of 
 
b
 
2
 
 integrins; mAb 60.1 recognizing integrin 
 
a
 
m
 
 chain
(CD11b); mAb DREG 200 and mAb SK11 against 
 
l
 
-selectin
(CD62L); and mAb G44-26 against CD44. Sheep IgG against
human elastase was from The Binding Site, and rabbit IgG against
human cathepsin G was from Athens Research and Technology,
Inc. mAbs to human elastase and cathepsin G were from Re-
search Diagnostics, Inc. and Chemicon International, respec-
tively. F(ab
 
9
 
)
 
2
 
 fragment of goat anti–mouse IgG was purchased
from Jackson ImmunoResearch Laboratories, Inc., and FITC-
conjugated F(ab
 
9
 
)
 
2
 
 fragment of rabbit anti–mouse IgG was from
Dako A/S.
 
ECs.
 
Bovine aorta ECs (BAECs) and human umbilical vein
ECs (HUVECs) were isolated and cultured as described previ-
ously (16). BAECs or HUVECs in the first to fifth passages were
detached by brief (2-min) trypsin-EDTA treatment (0.25%
trypsin/0.01% EDTA) and replated onto 3.0-
 
m
 
m pore size poly-
carbonate filters (tissue culture inserts, 10 mm; Nalge Nunc Inter-
national) or, for the purpose of visual inspection, 0.2 
 
m
 
m-pore
size Anopore inorganic membrane (transparent when wet; Nalge
Nunc International). To promote cellular differentiation and en-
hance attachment of ECs, the filters were pretreated with 50 
 
m
 
l
Biomatrix I (167 
 
m
 
g/ml) and air dried. ECs were seeded at a den-
sity of 2 
 
3 
 
10
 
5
 
 cells per filter and incubated in culture medium at
37
 
8
 
C in a humidified atmosphere of 5% CO
 
2
 
 in air. The ECs
were grown to confluent monolayers, as assessed by daily micro-
scopic observation in transparent 0.2-
 
m
 
m pore size filters and
measurement of the electrical resistance across the monolayer
(16). Under these experimental conditions, maximal resistance is
obtained at day 7 after seeding (16), at which day the EC mono-
layers were then used in the experiments.
 
Measurement of EC Barrier Function.
 
Two different approaches
were used for assessment of stimulation-induced changes in EC
permeability. For measurement of transendothelial electrical resis-
tance (TEER), the filter insert with ECs was transferred to a resis-
tance measurement chamber (16). The chamber (lower abluminal
compartment) with the filter insert (upper luminal
 
 
 
compartment),
filled with 2 ml and 400 
 
m
 
l culture medium, respectively, was
placed in a cell culture incubator. Electrical resistance across the
EC monolayer was measured at 37
 
8
 
C with an electrode in each
compartment exactly positioned in relation to each other and to
the monolayer. The electrical resistance of individual EC mono-
layers was obtained by subtracting the resistance of the corre-
sponding naked filter coated with Biomatrix as measured before
seeding of the ECs. TEER values so achieved represent the resis-
tance of the EC monolayer alone and depend on the develop-
ment of tight junctions between individual ECs (16).
In parallel experiments, Evans blue dye–conjugated albumin
(EBA) was used as a marker for macromolecular permeability of
the EC monolayers. Before stimulation of ECs, the culture me-
dium in the upper compartment was exchanged for medium con-
taining EBA (culture medium containing 4% BSA mixed with
Evans blue dye at a final concentration of 0.67 mg/ml). The EBA
concentration in fluid samples of the upper and lower compart-
ment was determined spectrophotometrically through measure-
ment of absorbency at 620 nm (Titertek Multiskan MCC; Flow
Laboratories). Albumin clearance was calculated according to the
relationship V1 
 
5 
 
A2 
 
3
 
 V2 
 
3
 
 1/A1, where V1 is the clearance
volume (i.e., the theoretical volume of the luminal medium
cleared from albumin by diffusion to the abluminal compart-
ment), V2 is the abluminal volume, and A1 and A2 are the absor-
bencies of the luminal and abluminal medium, respectively. The
baseline clearance in absence of any stimulus, 0.08 
 
6 
 
0.03 
 
m
 
l/
min, was subtracted from the clearance volume obtained in re-
sponse to respective specific stimulus.
 
Preparation and Quantification of PMNs.
 
Human PMNs were
isolated from leukocyte-rich plasma as described (16). Purity of
PMNs was 
 
.
 
98%, and viability by Trypan blue exclusion was
 
.
 
95%. Before being added to the EC monolayer, the PMNs
were pretreated with mAbs against cell surface molecules for sub-
sequent cross-linking with secondary antibody (see below). After
incubation with primary mAb (3 
 
m
 
g per 10
 
6
 
 PMNs) for 30 min at
room temperature, the cells were washed twice to remove un-
bound antibody and were resuspended in HBSS. PMNs not sub-
jected to antibody treatment were prepared according to the same 
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protocol, using vehicle instead of antibody. In some cases, cell
surface expression of CD11/CD18 was upregulated through tem-
perature transition of the PMNs before use. PMNs in the pres-
ence of anti-CD18 mAb IB4 were incubated at 4
 
8
 
C for 10 min,
transferred to 37
 
8
 
C for 10 min, and then returned to 4
 
8
 
C for an-
other 10 min, followed by two washes. There was no difference
in the EC responses to stimulation with these cells compared with
PMNs prepared according to the standard procedure.
PMN adhesion to ECs and transendothelial migration were
quantified by assaying the PMN-specific enzyme myeloperoxi-
dase (MPO). In brief, PMNs were lysed in 0.5% hexadecyltri-
methylammonium bromide and centrifuged, and the enzyme activ-
ity in the supernatant was determined spectrophotometrically as
the change in absorbency at 650 nm that occurs in the redox re-
action of H
 
2
 
O
 
2
 
-tetramethylbenzidine catalyzed by MPO (18).
MPO activity of adherent and transmigrated PMNs, respectively,
was related to that of the total number of PMNs added to the EC
monolayer.
 
Stimulation of ECs by Activated PMNs.
 
Before transferring the
filter insert to the resistance measurement chamber (kept at
37
 
8
 
C), the medium in the insert and in the chamber was replaced
with fresh culture medium (37
 
8
 
C) containing 20% FBS and sup-
plemented with 10 mM Hepes. PMNs (2 
 
3
 
 10
 
6
 
) with or without
mAbs bound to cell surface molecules were added to the upper
compartment (PMN/EC ratio 
 
5 
 
10:1) and allowed to sediment
for 10 min onto the EC monolayer. In separate experiments,
dextran sulfate (mol wt: 500,000; Amersham Pharmacia Biotech)
was added to the upper compartment at a final concentration of 1
mg/ml before PMN addition. Activation of PMN was induced
either with FMLP (10
 
2
 
7
 
 M) added to the upper compartment or
through antibody cross-linking of cell surface molecules by sec-
ondary goat anti–mouse IgG F(ab
 
9
 
)
 
2
 
 fragments (1:20). In each
single experiment, TEER was measured before and every minute
after start of stimulation until a plateau phase in the resistance
change was reached, and then at 5-min intervals. In experiments
where albumin permeability and PMN migration across the EC
monolayer were studied, the medium in the insert contained
EBA. After challenge, the filter insert was moved at 5–10-min in-
tervals to new wells containing fresh medium. All incubations
were performed at 37
 
8
 
C. At the end of the experiment, the lower
wells were centrifuged at 425 
 
g
 
 and 4
 
8
 
C for 20 min, and the su-
pernatant was analyzed for EBA content. PMNs that had mi-
grated across the monolayer were quantified through analysis of
MPO activity in the pellet remaining in the well. The medium in
the filter insert was aspirated for quantification of nonadherent
PMNs, and the filter membrane with ECs was removed from the
insert to quantify the adherent fraction of PMNs.
 
CD18 Cross-Linking–induced PMN Secretion.
 
Purified PMNs
in suspension (5 
 
3
 
 10
 
7
 
 cells/ml) pretreated with anti-CD18 mAb
IB4 according to the protocol described above were incubated
with or without goat anti–mouse F(ab
 
9
 
)
 
2
 
 for 10 min at 37
 
8
 
C. The
PMNs were sedimented by centrifugation at 300 
 
g
 
 for 15 min at
room temperature, and the cell-free supernatant containing PMN
secretion products was decanted for use in experiments with the
EC monolayers or in vivo (see below). The PMN postsecretory
supernatant was examined for the presence of proteins by SDS-
PAGE analysis. Proteins were separated on a 12% SDS polyacryl-
amide gel (Bio-Rad) under standard conditions and visualized in
gel by Coomassie blue staining (Bio-Rad). In addition, samples of
the postsecretory supernatant were applied to a cation exchange
column (HiTrap SP; Amersham Pharmacia Biotech) according to
the manufacturer’s instructions in order to remove positively
charged molecules from the supernatant.
 
To test the activity of the PMN postsecretory supernatant on
EC barrier function, the medium in the filter/EC insert was ex-
changed for 400 
 
m
 
l PMN secretion–containing medium supple-
mented with 20% FBS, and effects on TEER and albumin per-
meability were recorded as described. The amount of supernatant
added to each monolayer thus represented 10 times the number
of PMNs that were added to ECs in the case of direct CD18
cross-linking, as described above. In some cases, the postsecretory
supernatant was heat incubated (80
 
8
 
C for 15 min) before treat-
ment of ECs. The use of the PMN postsecretory supernatant to
stimulate ECs was combined in additional experiments with pre-
treatment of the monolayer with either the tyrosine kinase inhib-
itor herbimycin A (1 
 
m
 
M; Sigma-Aldrich) or the cell-permeant
Ca
 
2
 
1
 
 chelator BAPTA-AM (5 
 
m
 
M; Molecular Probes). EC
monolayers were incubated with the reagents for 30 min at 37
 
8
 
C
and washed twice before use. Stimulation of ECs with the post-
secretory supernatant was also induced in the presence of nega-
tively charged dextran sulfate. Dextran sulfate (mol wt: 500,000)
was added to the upper compartment at a final concentration of 1
mg/ml before stimulation.
PMN granule proteins cathepsin G and elastase have been sug-
gested to be capable of mediating changes in EC barrier capacity.
In an attempt to elucidate the potential involvement of cathepsin
G and/or elastase in the PMN-evoked effects on EC permeabil-
ity, it was sought to deplete the postsecretory supernatant of these
proteins by immunoadsorption. For this purpose, anti–cathepsin
G IgG or antielastase IgG was mixed with a slurry of protein A
sepharose CL-4B (Amersham Pharmacia Biotech) according to
the manufacturer’s instructions. The PMN postsecretory super-
natant obtained as above was incubated under gentle rotation for
15 min, first with anti–cathepsin G and then with antielastase-
coupled protein A sepharose (400 
 
m
 
g IgG/ml supernatant). After
each incubation step, the sepharose beads were sedimented by
centrifugation at 425 
 
g
 
 for 15 min, and the supernatant was de-
canted for further use. The efficacy of this procedure to deplete
the supernatant of these proteins was analyzed by sandwich
ELISA. In brief, microtiter plates were coated with 200 
 
m
 
l/well
of 0.25 
 
m
 
g/ml mAb to human cathepsin G or human elastase at
4
 
8
 
C, washed five times with PBS containing 0.05% Tween 20,
and blocked with 2% BSA (wt/vol) in PBS for 30 min at 37
 
8
 
C.
The plates were then incubated with a serial dilution (2
 
n
 
) of na-
tive and depleted supernatant, respectively, for 1 h at 37
 
8
 
C. After
washing, plates were incubated with rabbit anti–cathepsin G anti-
body or sheep antielastase antibody (dilution 1:1,000) for 1 h at
37
 
8
 
C. Bound antibody was detected by a horseradish peroxidase–
labeled secondary antibody to rabbit IgG and goat IgG, respec-
tively, and the chromogenic substrate diammonium-2,2
 
9
 
-azino-
bis-(3-ethyl-2,3-dihydrobenzthiazoline)-6-sulfonate/H
 
2
 
O
 
2
 
. The
relative protein content was spectrophotometrically determined.
 
Determination of EC Intracellular [Ca
 
2
 
1
 
] and F-actin Formation.
 
The Ca21-sensitive fluorescent probe fluo-3/AM (Molecular
Probes) was used for determination of changes in EC intracellular
free Ca21 ([Ca21 ]i). Confluent BAEC monolayers on filters were
incubated for 30 min at 378C with fluo-3/AM (3 mM in HBSS
containing 2% FBS and 10 mM Hepes) added to both the lumi-
nal and abluminal surface. The monolayers were washed three
times and incubated with fresh HBSS in the dark for 20 min at
room temperature to allow complete hydrolysis of the dye ester.
Anti-CD18 or anti–l-selectin mAb–treated PMNs were added to
ECs and allowed to settle for 10 min before receptor cross-link-
ing was accomplished with secondary antibody as described
above. Alternatively, mAb-treated PMNs were stimulated with
FMLP (1027 M). In separate experiments, PMN secretion–con-1832 Neutrophil-induced Alteration in Vascular Permeability
taining medium (described above) was used to stimulate ECs in
the absence of PMNs. Changes in EC [Ca21]i in response to these
stimuli (the latter also combined with BAPTA pretreatment of
ECs) were measured through continuous registration of fluores-
cence intensity with a laser-scanning confocal imaging system
(Insight Plus; Meridian Instruments).
For analysis of F-actin formation in ECs in response to PMN
activation, confluent EC monolayers grown on Biomatrix-coated
coverslips were incubated for 15 min at 378C with either PMN
subjected to CD18 antibody cross-linking or with PMN secre-
tion–containing medium identical to the procedures described
above. Incubation of ECs with IB4-treated PMN served as con-
trol. The monolayers were fixed in 3.7% formaldehyde in PBS
for 10 min at room temperature, washed twice, and permeabi-
lized with 0.2% Triton X-100 in PBS (1 min at 48C). The cells
were washed twice and stained for actin filaments with FITC-
conjugated phalloidin (Sigma-Aldrich) for 20 min at 378C. After
three additional washes, the ECs were viewed in a laser-scanning
confocal imaging system (Insight Plus; Meridian Instruments).
Visualization of b2 Integrin Cell Surface Distribution. PMNs,
preincubated with anti-CD18 mAb IB4 according to the proto-
col described above, were subjected to antibody cross-linking
with FITC-conjugated rabbit anti–mouse IgG F(ab9)2 fragments
for 2 min at room temperature. The reaction was stopped by fix-
ation in 3.7% formaldehyde for 10 min. Control PMNs were
fixed in the same way before incubation with secondary FITC-
conjugated F(ab9)2. The PMNs were washed twice and viewed
with laser-scanning confocal microscopy to visualize b2 integrin
receptor distribution on the PMN surface. Cell shape changes and
spreading of PMNs were observed with phase-contrast light mi-
croscopy 15 min after induction of CD18 cross-linking.
In Vivo Determination of Microvessel Permeability Changes. To
study the effect of PMN secretion products on microvessel per-
meability in vivo, intravital microscopy of the hamster cheek
pouch microcirculation was applied. As described previously in
detail (19), the left cheek pouch of anesthetized Syrian golden
hamsters was everted and prepared for microscopic observation
under continuous superfusion with a bicarbonate buffer maintain-
ing physiological levels of temperature, pH, and gas tensions.
FITC-conjugated dextran (mol wt: 150,000) injected intrave-
nously (250 mg/kg body weight) was used as plasma tracer to
permit visualization of changes in vascular permeability to macro-
molecules. The hamsters were treated with fucoidin (10 mg/kg
intravenously; Sigma-Aldrich) to prevent leukocyte adhesion in
the microvessels (20) and in that way eliminate influences of po-
tential activation of endogenous leukocytes. The microvascula-
ture in the exposed cheek pouch was observed under low magni-
fication in fluorescent light with a Leitz Orthoplan microscope
(Leica) and recorded on video. After control recordings, superfu-
sion was stopped and 1 ml of medium containing CD18 cross-
linking–evoked PMN secretion at 378C was topically applied to
the cheek pouch. In parallel experiments, medium of anti-
CD18–treated PMNs not subjected to cross-linking was used.
The animal experiments were approved by the regional ethical
committee for animal experimentation.
Results
Previously, we have shown that there is no qualitative
difference between responses of BAEC monolayers and
those of HUVECs to several experimental maneuvers, al-
though the results with BAECs are more consistent (16).
Accordingly, the data presented in this communication re-
fer to results obtained with BAECs, but confirmed in ex-
periments using HUVECs.
CD18 Cross-Linking in Quiescent PMNs Elicits a Prompt
Increase in EC Monolayer Permeability in the Absence of PMN
Adhesion and Transmigration. PMNs (2 3 106) pretreated
with anti-CD18 mAb (IB4) were added to the luminal side
of the EC/filter insert (upper compartment of the resistance
chamber) and allowed to settle for 10 min. CD18 cross-
linking with secondary goat anti–mouse F(ab9)2 elicited a
marked fall in TEER from a control value of 18.0 6 1.1
ohm3cm2 to 6.5 6 2.3 ohm·cm2 (means 6 SD; n 5 20).
The change in resistance was manifested within 1 min,
reached its lowest value (36 6 13% of control) after 15 min,
and remained at this level throughout the observation pe-
riod (Fig. 1). Treatment of PMNs with IB4 alone or with
secondary antibody in the absence of IB4 caused no change
in TEER (data not shown). PMNs were routinely added to
ECs at a ratio of 10:1. In pilot experiments, a ratio of 1:1
was also used, but without causing any change in resistance.
The capacity of CD18 cross-linking in causing increased
macromolecular flux and PMN migration across the EC
monolayer was studied in parallel experiments. PMNs pre-
treated with saturating concentration of IB4 were added to
the EC/filter insert and allowed to settle for 10 min in me-
dium containing EBA. CD18 cross-linking was then in-
duced with goat anti–mouse F(ab9)2, and the PMN/EBA–
containing filter inserts were moved at regular intervals to
new wells containing fresh medium. In the absence of sec-
ondary antibody, there was a minute and continuous clear-
ance of albumin, 0.08 6 0.03 ml?min21 (mean 6 SD; n 5
10), which did not change with time, and which exactly
matched the spontaneous clearance rate found in filter inserts
containing untreated PMNs (data not shown). In contrast,
activation of the PMNs by CD18 cross-linking elicited
augmented albumin clearance that increased progressively
with time (Fig. 1). The net increase in albumin clearance
Figure 1. Changes in TEER and macromolecular permeability (albu-
min clearance) of BAEC monolayers, and in PMN transmigration in re-
sponse to antibody cross-linking of leukocytic CD18. PMNs were prein-
cubated with anti-CD18 mAb for 30 min before being added to ECs.
Cross-linking with secondary F(ab9)2 was induced at time zero. Mean 6
SD; n 5 9–20.1833 Gautam et al.
rose from 0.5 6 0.1 ml during the first 5-min period to a
total of 20.0 6 4.5 ml (mean 6 SD; n 5 10) in 60 min.
Distinct from increased albumin clearance, CD18 cross-
linking caused no measurable PMN adhesion to ECs or
transendothelial migration (Fig. 1). Analysis of MPO activ-
ity in the two compartments 60 min after CD18 cross-link-
ing revealed that 91.0 6 6.0% (mean 6 SD; n 5 9) of
added PMNs were recovered in the medium of the upper
compartment, whereas no significant MPO activity was de-
tected in the EC/filter unit or in the medium of the lower
compartment. In separate experiments, direct microscopic
observation of transparent 0.2-mm pore size filters washed
at the end of the experiment confirmed complete absence
of PMNs adherent to the EC monolayer.
As opposed to treatment with anti-CD18 mAb alone,
cross-linking with secondary antibody induced prompt
clustering of b2 integrins on the cell surface, and as a conse-
quence of cell activation, pronounced shape changes and
spreading of the PMNs (Fig. 2). Notably, even though
PMNs were in close apposition to ECs, these responses oc-
curred in the absence of firm attachment of PMNs to the
monolayer, because this was prevented by CD18 mAb
treatment.
PMN-evoked Alteration in EC Permeability Is Specific to
CD11/CD18 Cross-Linking. Treatment of the PMNs
with IB4 prevented PMN adhesion to ECs and the change
in TEER in response to stimulation with FMLP (1027 M)
added to the upper compartment (Fig. 3 a). On the other
hand, subsequent cross-linking with secondary antibody
caused a change in TEER (from 19.0 6 1.5 ohm3cm2 to
7.0 6 1.5 ohm3cm2; means 6 SD; n 5 12) that was virtu-
ally identical to the response induced by FMLP stimulation
of untreated PMNs (Fig. 3 a). A similar decrease in TEER
to that found for CD18 cross-linking was observed after
cross-linking the am chain (CD11b) of b2 integrins in
PMNs pretreated with the anti-CD11b mAb 60.1 (Fig. 4).
To check for specificity of signaling via CD11/CD18 in
causing permeability changes in ECs, experiments were per-
formed with PMNs pretreated with mAb against l-selec-
tin (DREG-200 or SK11) or CD44 (G44-26). In this
case, cross-linking of l-selectin with goat anti–mouse
F(ab9)2 failed to induce any change in TEER. On the other
Figure 2.  a and b show confocal microscopic images of PMNs pre-
treated with anti-CD18 mAb and incubated with FITC-conjugated sec-
ondary F(ab9)2. The cells were fixed in formaldehyde either before or af-
ter 2-min incubation with the secondary antibody. (a) Staining for CD18
was weak and uniformly distributed in prefixed cells, whereas (b) redistri-
bution and clustering of b2 integrin receptors was evident in cells that
were fixed 2 min after CD18 cross-linking was induced. c and d show
light microscopic images of PMN pretreated with anti-CD18 mAb, be-
fore (c) and after (d) incubation with secondary F(ab9)2 for 15 min. Cell
spreading and pseudopod formation were clearly visible after CD18 cross-
linking. Micrographs are representative of .10 separate analyses. Bar in-
dicates 5 mm.
Figure 3. Kinetics of change in electrical resistance across BAEC
monolayers in response to PMN activation. (a) PMNs, preincubated with
anti-CD18 mAb and added to ECs, first were challenged with FMLP
(1027 M) and 15 min later were subjected to antibody cross-linking (x-
linking) of CD18 with secondary F(ab9)2 (d). Mean 6 SD; n 5 12. Note
lack of EC response to FMLP stimulation of the IB4-coated PMNs com-
pared with the response to FMLP stimulation (1027 M) of untreated
PMNs obtained in a separate set of experiments (s). Mean 6 SD; n 5 8.
(b) PMNs, preincubated with anti–l-selectin mAb, were added to ECs.
Cross-linking (x-linking) of l-selectin with secondary F(ab9)2 was in-
duced at time zero, followed by stimulation with FMLP (1027 M) at 15
min (mean 6 SD; n 5 6).1834 Neutrophil-induced Alteration in Vascular Permeability
hand, subsequent chemoattractant stimulation with FMLP
(102 7M) activated the PMNs and elicited a decrease
in TEER (from 19.4 6 2.0 ohm3cm2 to 5.5 6 1.5
ohm3cm2; means 6 SD; n 5 6), that was indistinguishable
from that of FMLP challenge of untreated PMNs (Fig. 3
b). Also, antibody cross-linking of CD44 had no effect on
TEER (Fig. 4), whereas subsequent PMN activation with
FMLP caused substantial decrease in TEER.
Alteration of EC Permeability in Response to CD18 Cross-
Linking Coincides with Increase in EC Cytosolic Free Calcium
and F-actin Content. In separate experiments, monolayers
of ECs were labeled with the Ca21-sensitive fluorophore
fluo-3, and stimulus-induced changes in EC [Ca21]i were
monitored by laser-scanning confocal microscopy. Addi-
tion of anti-CD18–pretreated PMNs to ECs and sedimen-
tation onto the monolayer, rendering PMNs in loose con-
tact with ECs, caused no change in EC [Ca21]i. However,
CD18 cross-linking with secondary antibody elicited a
rapid increase in EC cytosolic free [Ca21], which peaked
within 100–200 s and then slowly subsided (Fig. 5). Anti-
body cross-linking of l-selectin in an equivalent manner
failed to induce any change in EC [Ca21]i (data not
shown). A Ca21 response similar to that induced by CD18
cross-linking was seen after stimulation of untreated PMNs
with FMLP (16), whereas chemoattractant stimulation of
IB4-coated PMNs was unable to cause a rise in EC [Ca21]i
(Fig. 5), reflecting the necessity of b2 integrin engagement
(adhesion dependent or antibody induced) in signaling
PMN-evoked EC calcium responses.
In further experiments, EC monolayers were incubated
with PMN and then stained for actin filaments with FITC-
conjugated phalloidin. Laser-scanning confocal microscopy
revealed that ECs incubated with IB4-treated PMNs in the
absence of secondary antibody exhibited few stress fibers
and a thin band of actin along cell margins in direct apposi-
tion to adjacent cells (Fig. 6 a). On the other hand, ECs in-
cubated with PMNs subjected to CD18 cross-linking pre-
sented a marked increase in the number and density of
F-actin stress fibers (Fig. 6 b).
CD18 Cross-Linking Triggers PMN Secretion that Mediates
Alterations in EC Permeability. The finding that PMN ac-
tivation through antibody cross-linking of CD18 altered
the characteristics of the endothelium, although there was
no PMN attachment to the monolayer, prompted us to in-
vestigate if factor(s) secreted by the PMNs mediated the re-
sponse ultimately leading to increased EC permeability.
Thus, PMNs pretreated with anti-CD18 mAb IB4 and
washed to remove unbound antibody were incubated with
goat anti–mouse F(ab9)2 for 30 min, then spun down by
gentle centrifugation. Analysis of the cell-free supernatant
by SDS-PAGE and Coomassie staining indicated a promi-
nent fraction of proteins with apparent molecular mass in
the range of 25–30 kD (Fig. 7). Presumably, the majority
of these proteins were positively charged because the cor-
responding bands disappeared after running the supernatant
through a cation exchange column (Fig. 7).
Addition of 400 ml cell-free supernatant to the EC
monolayer, corresponding to a PMN/EC ratio of 100:1,
elicited a fall in TEER (from 17.8 6 1.0 ohm3cm2 to 5.1 6
2.1 ohm3cm2; means 6 SD; n 5 10) and an increase in
albumin clearance, both of which had the same magnitude
and time course as after CD18 cross-linking in PMNs
added to ECs (Fig. 8 a). These responses were tyrosine ki-
nase dependent, inasmuch as pretreatment of ECs with
herbimycin A significantly attenuated the permeability
change (Fig. 8 b). Also, the supernatant caused changes in
EC [Ca21]i and in F-actin content and distribution, which
closely resembled those documented in Figs. 5 and 6 for di-
Figure 4. Magnitude of TEER changes in BAEC monolayers in re-
sponse to different modes of PMN activation according to protocols de-
scribed in Materials and Methods. Antibody cross-linking (x-linking) of
either CD11b or CD18 b2 integrin subunit resulted in a decrease in EC
electrical resistance of the same magnitude as that induced by FMLP stim-
ulation, whereas FMLP stimulation of IB4-coated PMNs (FMLP 1 anti-
CD18) and cross-linking (x-linking) of l-selectin or CD44 failed to in-
duce any change in resistance. Data are means 6 SD based on 6–20
experiments in each group.
Figure 5. Effect of PMN activation on EC cytosolic free [Ca21].
PMNs, preincubated with anti-CD18 mAb, were layered on fluo-3–
loaded BAEC monolayers. Antibody cross-linking of CD18 with second-
ary F(ab9)2 was induced at time zero. Tracings show fluorescence intensity
changes in four individual ECs of the same monolayer normalized to the
average fluorescence intensity before stimulation. Dotted curve illustrates
response to FMLP stimulation of anti-CD18 mAb–treated PMNs. Trac-
ings are representative of responses in 10 separate monolayers.1835 Gautam et al.
rect PMN stimulation of ECs. A causal link between
changes in intracellular Ca21 activity and the functional re-
sponse of ECs to PMN activation was evidenced by exper-
iments where ECs were pretreated with the calcium-
chelating agent BAPTA-AM. This treatment completely
inhibited both the rise in EC [Ca21]i (data not shown) and
the change in TEER in response to CD18 cross-linking
(Fig. 8 b).
The presence of cationic proteins in the secreted material
prompted us to examine whether the permeability-increas-
ing activity was in fact due to this protein fraction. This
was clearly suggested to be the case, as there was no change
in TEER in response to stimulation with supernatant de-
pleted of cations (Fig. 8 b). To test the hypothesis that the
activity of the postsecretory supernatant could potentially
be due to charge-related effects of the neutrophil-derived
cationic proteins, we sought to neutralize such activity
through addition of the polyanion dextran sulfate to the
medium of the EC monolayer. Indeed, in the presence of
dextran sulfate (1 mg/ml), stimulation with the postsecre-
tory supernatant proved ineffective in inducing EC perme-
ability changes (Fig. 8 b). The ability of dextran sulfate to
prevent the EC response to stimulation with cell-free su-
Figure 6. Effect of PMN activation on
EC F-actin formation. PMNs, pretreated
with anti-CD18 mAb, were added to
BAEC monolayers and incubated with or
without secondary F(ab9)2. (a) Staining for
actin filaments with FITC-conjugated phal-
loidin revealed few stress fibers and a thin
band of actin along cell margins in ECs in-
cubated with PMNs in absence of secondary
antibody. (b) In contrast, ECs exposed to
PMNs subjected to antibody cross-linking
of CD18 exhibited a marked increase in
F-actin and density of stress fibers spanning the
cells. Micrographs are representative of .20
separate experiments. Bar indicates 25 mm.
Figure 7. SDS-PAGE analysis of cell-
free supernatant obtained after CD18
cross-linking in suspended PMNs. Coo-
massie blue staining revealed multiple
bands corresponding to proteins with
apparent molecular mass of 25–30 kD
(left lane). After running the supernatant
through a cation exchange column, the
majority of these bands were missing
(right lane). Molecular mass is indicated
on the left.
Figure 8.  (a) Kinetics of changes in TEER and macromolecular per-
meability (albumin clearance) of BAEC monolayers stimulated with cell-
free supernatant obtained after CD18 cross-linking in suspended PMNs.
The medium in the filter/EC insert was exchanged at time zero for me-
dium containing CD18 cross-linking–evoked PMN secretion. Means 6
SD; n 5 10). (b) Magnitude of TEER changes in response to stimulation
of EC monolayers with the PMN postsecretory supernatant. Indicated in
the figure are effects of the PMN-derived secretion on ECs pretreated
with calcium-chelator BAPTA-AM or tyrosine-kinase inhibitor herbi-
mycin A, and of challenge with PMN secretion in the presence of dex-
tran sulfate. Also shown is the loss of activity of postsecretory supernatant
after cation depletion, whereas specific immunoabsorption of cathepsin G
and elastase does not significantly attenuate the TEER response. Data are
means 6 SD based on 6–10 experiments in each group.1836 Neutrophil-induced Alteration in Vascular Permeability
pernatant raised the question of whether this treatment
could also inhibit the response to direct PMN activation.
This was confirmed in experiments where PMNs sedi-
mented on ECs were activated either by antibody cross-
linking of CD18 (IB4-coated PMNs) or by FMLP (un-
treated PMNs) in the presence of dextran sulfate (1 mg/
ml). In both cases, the fall in TEER was almost completely
prevented by dextran sulfate (TEER decreased only by 3 6
5% and 5 6 4%, respectively; means 6 SD; n 5 6).
Having demonstrated that the PMN-derived secretion
exerted its effect on EC permeability because its polycat-
ionic nature, we went on by examining whether neutro-
phil-derived cathepsin G and/or elastase could be responsi-
ble for communicating this effect, as both these proteins,
potentially released from the activated PMN, have been
shown previously to be capable of inducing EC permeabil-
ity changes. By specific immunoadsorption, there was com-
plete removal of cathepsin G and elastase from the post-
secretory supernatant, as verified by sandwich ELISA for
the two proteins, respectively (data not shown). However,
functional analysis revealed that the activity of the PMN-
derived secretion was independent on these proteins, be-
cause postsecretory supernatant depleted of both proteins
induced a fall in TEER of the same magnitude as that
evoked by stimulation with native supernatant (Fig. 8 b).
CD18 Cross-Linking–evoked PMN Secretion Induces Venu-
lar Plasma Leakage In Vivo. Topical administration of the
PMN postsecretory supernatant to the hamster cheek
pouch in vivo  preparation elicited prompt leakage of
plasma from postcapillary and small venules (Fig. 9). Leaky
spots were observed within 3 min after application, and in-
creased progressively in number and intensity with time.
After wash of the tissue with buffer, the leakage slowly
subsided. This effect on microvessel permeability was lost
after heat treatment of the PMN-derived secretion, indi-
cating that a heat-sensitive factor(s) was responsible for its
permeability-increasing activity. Application to the cheek
pouch of supernatant of IB4-coated PMN, not subjected
to cross-linking, did not cause any visible plasma leakage
(data not shown).
Discussion
PMN adhesion to the endothelial lining and recruitment
to extravascular tissue in acute inflammation is critically de-
pendent on the function of b2 integrins. Increased vascular
permeability for macromolecules is induced in conjunction
with this cellular response, leading to plasma exudation and
edema formation. Here, we provide evidences for a causal
connection between transmembrane signaling by the b2 in-
tegrins in PMNs and the capacity of these cells to induce
alterations in EC barrier function. We show that engage-
ment of b2 integrins initiates PMN activation and secretion
that triggers an active tyrosine kinase–dependent response
of ECs, involving cytoskeletal reorganization and intercel-
lular gap formation that gives rise to increased EC perme-
ability.
Increased vascular permeability for plasma components is
a cardinal feature of acute inflammation. Besides being in-
duced by directly acting agonists, plasma leakage is causally
linked to the activation and tissue recruitment of circulating
PMNs. Because of the important homeostatic function of
EC as a selective barrier between blood and tissue, PMN-
induced EC barrier dysfunction has been implicated in the
pathogenesis of a number of inflammatory disorders. b2 in-
tegrin (CD11/CD18)–mediated PMN attachment to ECs
is required for the activated PMNs to induce changes in EC
integrity (2, 21–23). Although dependent on this early
physical interaction, the EC response appears unrelated, at
least initially, to subsequent PMN transmigration (16, 17).
To explore mechanisms by which adherent PMNs may
transfer signals to ECs in this process, we simulated PMN–
EC interactions and adhesion-dependent engagement of b2
integrins through antibody cross-linking of CD11/CD18.
Although engagement of b2 integrins in the physiological
setting requires agonist-induced PMN activation and adhe-
sion to a biological surface, antibody cross-linking of the
common b chain or the distinct a chains of b2 integrins
provides a means to explore signaling properties of b2 inte-
grins in PMN functional responses. These include, for ex-
ample, mobilization of [Ca21]i, cytoskeletal rearrangement,
Figure 9. In vivo fluorescence micrographs of the hamster cheek
pouch microcirculation before (a) and 10 min after (b) topical application
of medium containing CD18 cross-linking–evoked PMN secretion, at
378C. FITC-dextran injected intravenously served as plasma tracer. Leak-
age of plasma from postcapillary and small venules was evident within 3
min after stimulation and increased progressively. After wash of the tissue
with buffer, the leaky spots disappeared slowly. Bar indicates 200 mm.1837 Gautam et al.
oxidative burst, and release of granule components. How-
ever, to date there has been no demonstration implying a
causal association between PMN activation via this mode
of stimulation and effects on EC barrier function. We show
that antibody-induced ligation and clustering of b2 inte-
grins triggers an increase in EC permeability matching that
seen after chemoattractant-induced PMN adhesion to ECs.
What is more, the cellular crosstalk initiated by CD18
cross-linking occurred in the absence of physical binding of
PMNs to ECs (prevented by anti-CD18 mAb), indicating
that the signal transfer from leukocyte to endothelium is
not effected via a structural linkage between CD11/CD18
and counterreceptors on the EC surface. Instead, signaling
is likely to be accomplished via PMN-derived secretion.
Such a paracrine mechanism is further substantiated by the
capacity of the cell-free supernatant, obtained after anti-
body cross-linking of CD18 in suspended PMN to induce
EC hyperpermeability. On the other hand, mere activation
of the leukocyte b2 integrins by FMLP is insufficient to
elicit the secreted factor. Cell-free supernate recovered
from such PMNs activated in suspension failed to induce
changes in EC permeability (21; our unpublished data). It
thus appears that both activation and engagement of the in-
tegrins with the endothelial surface (the latter mimicked
experimentally by cross-linking the anti-CD18 antibody) is
required for secretion of this factor(s).
The capacity of PMN cell surface molecules to signal al-
terations in EC barrier function was restricted to the b2 in-
tegrins. Antibody cross-linking of l-selectin or CD44 did
not result in any functional response of ECs, and blockade
of these receptor functions did not influence the EC re-
sponsiveness to chemoattractant stimulation. Interestingly,
l-selectin cross-linking in PMN has been reported to ini-
tiate intracellular activation events, as indicated by in-
creased levels of cytosolic free Ca21 and induction of oxi-
dative burst (24, 25). In line with these observations, we
have found that l-selectin cross-linking causes elevations in
PMN [Ca21]i that are similar to those obtained with CD18
cross-linking (our unpublished data). Yet, the divergent re-
sponses with regard to effect on EC barrier function indi-
cate that distinct signaling mechanisms are elicited by en-
gagement of l-selectin and CD11/CD18, respectively. The
signal transduction pathways initiated by integrin ligation
are highly complex, and the contribution of various intra-
cellular regulatory proteins to the PMN response ultimately
leading to secretion is unknown. Nevertheless, our data
demonstrate that the signaling cascade initiated by ligation
and clustering of b2 integrins is not only essential, but also
is sufficient for triggering PMN responses that lead to alter-
ations in EC permeability.
Antibody-induced engagement of CD11/CD18 led to
secretion of PMN proteins, with apparent molecular mass
in the range of 25–30 kD and seemingly responsible for
mediating the PMN-evoked change in EC permeability. A
vast number of proteins are kept in different storage or-
ganelles of the PMN and may be mobilized upon cell acti-
vation (26). For example, azurophil granules contain a
family of antimicrobial cationic glycoproteins that have
extensive homology to one another and have molecular
weights similar to that found for the secreted proteins in
our experiments. Members of this family, cathepsin G and
elastase, have in various model systems been reported to in-
duce EC barrier dysfunction (27–30). Presumably, this is
because of their positive surface charge, as neutralization
with polyanions (e.g., heparin, dextran sulfate) inhibits
their capability, as well as that of cationic polyamino acids,
to induce EC hyperpermeability (28, 31). However, the
finding that the permeability-increasing activity of the
PMN-derived secretion remained after immunoabsorption
of potentially released cathepsin G and/or elastase refutes
the involvement of these proteins in the EC responses to
PMN activation. Nevertheless, our findings that PMN-
induced alterations in EC barrier function were totally pre-
vented in the presence of dextran sulfate, combined with
the observation that cation-depleted PMN secretion lost its
permeability-increasing activity, suggest a mechanistic basis
for PMN–EC intercellular crosstalk that involves paracrine
signaling via PMN-derived cationic protein(s).
PMN activation through antibody engagement of b2 in-
tegrins initiated an active response in adjacent EC, as evi-
denced by rapid mobilization of cytosolic free Ca21 and
redistribution of actin filaments, leading to structural re-
arrangement of the EC cytoskeleton and impaired barrier
function. The EC responses to CD18 cross-linking in
PMNs resembled those evoked by chemoattractant-induced
PMN activation (16, 17), suggesting a basic principle by
which activated PMNs may regulate EC barrier function.
Increase in EC permeability has been shown to be associ-
ated with calcium-dependent conformational changes of
the EC cytoskeleton, leading to cell contraction and in-
tercellular gap formation (32, 33). Reorganization of actin
filaments is essential for these cell shape changes, and for-
mation of F-actin may thus be an important determinant of
increased EC permeability (34). We found that stimulation
of ECs through PMN activation resulted in loss of periph-
eral actin bands and increased stress fiber density similar to
what has been shown to be associated with agonist-induced
(e.g., histamine, thrombin) increases in EC permeability
(34, 35). EC shape changes due to actin polymerization and
cytoskeletal reorganization are dependent on tyrosine ki-
nase activity (36, 37). Because pretreatment of ECs with
herbimycin A largely attenuated the EC permeability re-
sponse to PMN activation, a coupling is provided between
the PMN-derived stimulus and phosphorylation of cyto-
skeletal proteins, leading to impaired barrier capacity. This is
in line with recent observations on activation of EC myo-
sin light chain kinase by chemoattractant-stimulated PMNs
(38, 39). The critical role of calcium-dependent active pro-
cesses in ECs for manifestation of the PMN-induced per-
meability change was further indicated by the finding that
chelation of EC intracellular Ca21 totally prevented the in-
crease in EC permeability.
In conclusion, as demonstrated in vitro and confirmed in
vivo, antibody cross-linking of b2 integrins (CD11/CD18)
initiates a functional response in quiescent PMN that pro-
vokes cytoskeletal rearrangement in adjacent ECs and in-1838 Neutrophil-induced Alteration in Vascular Permeability
crease in EC permeability, which is identical to the re-
sponse seen after chemoattractant-induced PMN activation.
Our data suggest, with reference to the inflammatory reac-
tion in vivo, that stimulus-induced PMN adhesion to the
vascular endothelium initiates PMN secretion consequent
to b2 integrin signaling, which capacitates changes in en-
dothelial barrier function that are independent of PMN
transmigration. These findings provide novel information
with regard to the role of b2 integrins in PMN-evoked ef-
fects on vessel wall permeability in conjunction with neu-
trophil trafficking in inflammation.
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